What Happened?
Washington, -based 54gene Promoted Teresia Bost as General Counsel and Interim Chief Executive Officer
About the Company
54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market; Nearly 90% of genetic material used in pharmaceutical research is Caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
About the Person
Teresia Bost is General Counsel and Interim Chief Executive Officer at 54gene. Previously, Teresia held various senior legal leadership roles in the industry.
Info Source
News
Short Profile